XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Commitments and Contingencies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Commitments And Contingencies Disclosure [Abstract] |
Summary of Outstanding Non-cancelable Purchase Obligations | As of December 31, 2021, the Company had the following outstanding non-cancelable purchase obligations (in thousands):
|  | Purchase Obligations Due In The Year Ending December 31, |
|  | 2022 |  |  | 2023 |  |  | Total |
|  | (in thousands) |
Manufacture and supply of pamrevlumab |  | $ | 25,480 |  |  | $ | 19,918 |  |  | $ | 45,398 |
Manufacture and supply of roxadustat |  |  | 14,591 |  |  |  | 3,920 |  |  |  | 18,511 |
Other purchases |  |  | 9,353 |  |  |  | — |  |  |  | 9,353 |
Total purchase obligations |  | $ | 49,424 |  |  | $ | 23,838 |  |  | $ | 73,262 |

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of unconditional purchase obligation recognized as liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=123406679&loc=d3e25383-109308 + Details
Name: | us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration